KS-TEXTRON-AVIATION
27.5.2024 10:01:30 CEST | Business Wire | Press release
Textron Aviation today announced advanced Garmin G5000 avionics enhancements coming to the best-selling mid-size business jet, the Cessna Citation Latitude, and the flagship of the Citation family of jets, the Citation Longitude. Textron Aviation’s investments in the popular business jets, based on customer feedback, will offer greater performance and improved user experience to pilots in the new Latitude jets beginning in 2025 and the new Longitude jets in 2026.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240527032307/en/
Textron Aviation | Cessna Citation Jets (Photo: Business Wire)
The Cessna Citation Latitude and Cessna Citation Longitude are designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company.
"Citation jets offer customers performance, productivity and profitability that opens a new world of possibility in aviation and their business,” said Lannie O'Bannion, senior vice president of Global Sales & Flight Operations. "These enhancements demonstrate our commitment to continuously invest in our legendary products in order to design and deliver the best aviation experience for our customers.”
When equipped with the latest Garmin G5000 avionics suite, the Latitude and Longitude will feature an array of new advanced features and technology from Garmin, including Synthetic Vision Guidance System (SVGS) shown on the primary flight displays, that couples with Synthetic Vision Technology (SVT) to support approach minima as low as 150 ft (46 m). SVGS provides a continuous, geo-spatially correct depiction of the external scene topography, including obstacles, augmented by the display of the runway.
SVT enhancements include a 3D exocentric view of the SafeTaxi® airport environment to aid situational awareness while taxiing. SVT also displays 3D building footprints including hangars, terminals and towers, taxiways, aprons, signs and other markings to help reduce runway incursions by providing guidance while taxiing at airports contained in the SafeTaxi database. The enhancements also support pilot situational awareness by increasing topographical clarity, sharpening water and terrain boundaries, improving obstacle and powerlines display and enhancing runway and airport sign depictions. SVT introduces multiple viewpoints for the first time and integrates with the new Taxiway Routing feature that provides clarity during ground operations – particularly at large, unfamiliar and complex airports during low visibility conditions.
The Latitude and Longitude can utilize the standard ADS-B In capability for Cockpit Display of Traffic Information (CDTI) Assisted Visual Separation (CAVS). CAVS increases pilots’ traffic awareness and assists pilots in maintaining separation from preceding aircraft equipped with ADS-B out during visual approaches to landing. SURF IA also utilizes ADS-B data to provide alerts when attempting a takeoff or landing on an occupied runway.
For qualifying regions, the GDL 60 Datalink offers high-bandwidth data exchange and connectivity options, including Bluetooth, Wi-Fi and LTE networks. The GDL 60 features the ability to complete automatic wireless database downloads over network connections while the aircraft is powered off. Additionally, enhancements to the GDL 69A allow the Garmin G5000 suite to access more SiriusXM Weather products.
Cessna Citation jets are versatile and reliable business tools that enable customers to fulfil a wide range of missions. The Citation Latitude has been the world’s most-delivered midsize business jet for eight consecutive years and has proved a hit with customers due to its reliability, versatility and impressive range. The Citation Longitude is equally designed around the pilot experience, passenger comfort and overall performance, delivering an aircraft that lives up to its designation as the flagship of the Citation family of business jets.
About the Cessna Citation Latitude
The Citation Latitude midsize business jet, with a four-passenger range of 2,700 nautical miles (5,000 km) at high-speed cruise, is set apart from the competition by its combination of comfort and efficiency. The aircraft’s class-leading take-off field length of 3,580 feet provides operators with greater range out of short fields. Inside, the Citation Latitude offers an unrivaled cabin experience featuring the most open, spacious, bright and refined cabin environment in its category. With a flat floor and six feet of cabin height, innovation abounds with exceptional features designed throughout the aircraft.
About the Citation Longitude
With a range of 3,500 nautical miles (6,482 kilometers) and full fuel payload of 1,600 pounds (726 kilograms), the Citation Longitude elevates passenger experience in the super-midsize class by delivering cabin sound levels that are nearly twice as quiet as the nearest competitor, a low cabin altitude (5,950 feet/1,814 meters), more standard features and an elegant yet comfortable, bespoke interior. No other super-midsize business jet offers more range, greater payload or higher cruise speed at a lower direct operating cost.
About Textron Aviation
We inspire the journey of flight. For more than 95 years, Textron Aviation Inc., a Textron Inc. company, has empowered our collective talent across the Beechcraft, Cessna and Hawker brands to design and deliver the best aviation experience for our customers. With a range that includes everything from business jets, turboprops, and high-performance pistons, to special mission, military trainer and defense products, Textron Aviation has the most versatile and comprehensive aviation product portfolio in the world and a workforce that has produced more than half of all general aviation aircraft worldwide. Customers in more than 170 countries rely on our legendary performance, reliability and versatility, along with our trusted global customer service network, for affordable and flexible flight.
For more information, visit www.txtav.com | www.defense.txtav.com | www.scorpionjet.com.
About Textron Inc.
Textron Inc. is a multi-industry company that leverages its global network of aircraft, defense, industrial and finance businesses to provide customers with innovative solutions and services. Textron is known around the world for its powerful brands such as Bell, Cessna, Beechcraft, Pipistrel, Jacobsen, Kautex, Lycoming, E-Z-GO, Arctic Cat, Textron Systems, and TRU Simulation. For more information, visit: www.textron.com
Certain statements in this press release are forward-looking statements which may project revenues or describe strategies, goals, outlook or other non-historical matters; these statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements. These statements are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240527032307/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom